|
Real-time
Euronext Paris
10:25:16 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 23.74 EUR | +2.33% |
|
+6.27% | -5.79% |
| 09-02 | Medincell Names Chief Medical Officer | MT |
| 09-01 | Medincell Announces Appointment of Edna Venneker as Chief Medical Officer | CI |
| Market Cap | 833M 949M 783M 716M 1.34B 90.93B 1.35B 9.41B 3.65B 46.36B 3.56B 3.49B 150B | P/E 2027 * |
387x | P/E 2028 * | 48.7x |
|---|---|---|---|---|---|
| Enterprise Value | 818M 932M 769M 703M 1.31B 89.31B 1.32B 9.24B 3.58B 45.53B 3.5B 3.42B 148B | EV / Sales 2027 * |
18.5x | EV / Sales 2028 * | 13.6x |
| Free-Float |
66.06% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| MEDCL | Real-time | |
London S.E.
| 0ACH | Delayed | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| MEB | Delayed | |
|
Boerse Muenchen
| MEB | Real-time | |
|
Tradegate
| MEB | Real-time | |
|
Deutsche Boerse AG
| MEB | Delayed | |
|
CBOE
| 0ACH | Real-time |
Last Transcript: MedinCell S.A.
| 1 day | +2.33% | ||
| 1 week | +6.27% | ||
| Current month | -2.06% | ||
| 1 month | -2.30% | ||
| 3 months | -5.12% | ||
| 6 months | +13.70% | ||
| Current year | -5.79% |
| 1 week | 21.4 |  | 24.2 |
| 1 month | 21.08 | | 24.96 |
| Current year | 19.69 | | 29.76 |
| 1 year | 19.69 | | 39.68 |
| 3 years | 5.25 | | 39.68 |
| 5 years | 4.73 | | 39.68 |
| 10 years | 4.35 | | 39.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 62 | 2003-01-08 |
Stéphane Postic
DFI | Director of Finance/CFO | 52 | 2023-08-31 |
Edna Venneker
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Douat
BRD | Director/Board Member | 62 | 2003-01-08 |
Philippe Guy
CHM | Chairman | - | 2024-03-12 |
Virginie Lleu
BRD | Director/Board Member | - | 2016-05-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/26/25 | Buy | General Counsel | 2,943 | 0.0099% | ||
| 2/21/25 | Buy | Chief Financial Officer | 3,749 | 0.0126% | ||
| 5/6/23 | Sell | Founder | 60,000 | 0.2376% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.33% | +6.27% | +5.42% | +281.06% | 949M | |
| +3.65% | +3.34% | +60.53% | +115.63% | 1,026B | |
| +1.62% | +1.32% | +54.95% | +70.83% | 649B | |
| +0.52% | +0.63% | +20.77% | +71.79% | 468B | |
| +0.44% | +0.91% | +40.25% | +46.06% | 352B | |
| +1.59% | +2.90% | +22.03% | +29.06% | 271B | |
| +0.31% | +0.40% | +11.31% | +11.47% | 256B | |
| +0.32% | +7.30% | +45.94% | +52.70% | 220B | |
| +0.76% | +1.05% | +34.13% | +103.76% | 188B | |
| +0.35% | -9.45% | -31.92% | -60.30% | 170B | |
| Average | +1.16% | +1.87% | +26.34% | +72.21% | 360.01B | |
| Weighted average by Cap. | +1.62% | +1.26% | +39.33% | +68.42% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 44.14M 50.29M 41.49M 37.94M 70.89M 4.82B 71.42M 498M 193M 2.46B 189M 185M 7.96B | 58.92M 67.13M 55.39M 50.64M 94.62M 6.43B 95.33M 665M 258M 3.28B 252M 247M 10.63B |
| Net income | 667K 760K 627K 573K 1.07M 72.76M 1.08M 7.53M 2.92M 37.1M 2.85M 2.79M 120M | 13.33M 15.18M 12.53M 11.45M 21.4M 1.45B 21.56M 150M 58.33M 742M 57.02M 55.77M 2.4B |
| Net Debt | -14.87M -16.94M -13.97M -12.78M -23.88M -1.62B -24.05M -168M -65.07M -827M -63.61M -62.21M -2.68B | -30.53M -34.79M -28.7M -26.24M -49.03M -3.33B -49.4M -345M -134M -1.7B -131M -128M -5.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | €23.74 | +2.33% | 53,581 |
| 26-09-23 | €23.20 | +2.47% | 107,380 |
| 26-09-22 | €22.64 | +4.14% | 74,674 |
| 26-09-21 | €21.74 | -0.09% | 69,718 |
| 26-09-18 | €21.76 | -2.60% | 90,196 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDCL Stock
Select your edition
All financial news and data tailored to specific country editions
